🇺🇸 FDA
Patent

US 6358947

Tetracyclic progesterone receptor modulator compounds and methods

expired A61PA61P15/18A61P35/00

Quick answer

US patent 6358947 (Tetracyclic progesterone receptor modulator compounds and methods) held by Ligand Pharmaceuticals Incorporated expires Mon Mar 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue Mar 19 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P15/18, A61P35/00, A61P5/24, A61P5/26